Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05ORO
|
|||
| Former ID |
DIB002359
|
|||
| Drug Name |
Anti-N3pG-Abeta antibody
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01837641) A Study of LY3002813 in Participants With Alzheimer's Disease. U.S. National Institutes of Health. | |||
| REF 2 | LY3002813 Alzheimer's Disease (Phase 1). Eli Lilly & Co. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.